Cite
HARVARD Citation
Gschwend, J. et al. (n.d.). 820PCabazitaxel under routine conditions for the treatment of patients with metastatic castration-resistant prostate cancer (mCRPC): Interim results of the non-interventional SCOPE study. Annals of oncology. p. . [Online].